Executive Editor
- Dafne Solera, BioMed Central
Editorial Board | Editorial Team | Instructions for authors | FAQ
Articles
-
BMC Clinical Pharmacology 2011, 11:15Gastrointestinal side effects of varenicline
Evidence from published randomized controlled trials indicates that the smoking cessation aid varenicline is associated with major gastrointestinal adverse effects at maintenance dose of 1 mg twice a day for longer than 6 weeks.
-
BMC Clinical Pharmacology 2011, 11:14Improving adverse drug reaction reporting
Repeated distribution of adverse drug reaction (ADR) information letters fails to increase the ADR reporting rate in Swedish primary healthcare units, though the number of high quality reports detailing serious or unexpected reactions does increase.
Hot topic
Immunogenicity of panitumumab in combination chemotherapy clinical trials
BMC Clinical Pharmacology 2011, 11:17 (9 November 2011)
Scope
BMC Clinical Pharmacology is an open access, peer-reviewed journal that considers articles on all aspects of clinical pharmacology.
From the blog
- 08 February 2012
- Invitation to submit to Cancer Bioinformatics thematic series
- 30 January 2012
- BMC-series journals on track for Impact Factor
- 18 January 2012
- Bacterial symbionts – the key to fighting pests and diseases?
Quote
"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."
Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA
Email alerts
Receive periodic news and updates relating to BioMed Central.
RSS
Comments
View more comments